A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia

Rachel J. Bailen, Monica I. Aasum, Linda M. Tamminga, Amber B. Koehler, Amy L. Behnken, Jen Harden, Paul J. Hampel, Yucai Wang, Eli Muchtar, Saad S. Kenderian, Neil E. Kay, Kari G. Rabe, Wei Ding, Timothy G. Call, Sameer A. Parikh

Journal of Oncology Pharmacy Practice

Published online on April 02, 2025

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
PurposeVenetoclax-based treatment for chronic lymphocytic leukemia (CLL) can be a logistically burdensome regimen due to extensive required monitoring of tumor lysis syndrome (TLS). The purpose of this study was to evaluate the feasibility and safety of ...